TrialCNS neuroscience & therapeutics2022

Results from a multicenter, randomized, double-blind, placebo-controlled study of repository corticotropin injection for multiple sclerosis relapse that did not adequately respond to corticosteroids.

Daniel Wynn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.